62

Bioinformatics of the Brain

[19] X. Gao, C. Xu, N. Asada, et al., “The hematopoietic stem cell niche:

from embryo to adult.,” Development (Cambridge, England), vol. 145,

1 2018.

[20] A. Y. Lai and M. Kondo, “T and b lymphocyte differentiation from

hematopoietic stem cell,” Seminars in Immunology, vol. 20, pp. 207–

212, 8 2008.

[21] K. Weiskopf, P. J. Schnorr, W. W. Pang, et al., “Myeloid cell origins,

differentiation, and clinical implications,” Microbiology Spectrum, vol. 4,

10 2016.

[22] E. D. Thomas, H. L. Lochte, W. C. Lu, et al., “Intravenous infusion of

bone marrow in patients receiving radiation and chemotherapy,” New

England Journal of Medicine, vol. 257, pp. 491–496, 9 1957.

[23] I. Henig and T. Zuckerman, “Hematopoietic stem cell transplantation—

50 years of evolution and future perspectives,” Rambam Maimonides

Medical Journal, vol. 5, p. e0028, 10 2014.

[24] K. Takahashi and S. Yamanaka, “Induction of pluripotent stem cells

from mouse embryonic and adult fibroblast cultures by defined factors,”

Cell, vol. 126, pp. 663–676, 8 2006.

[25] K. Takahashi, K. Tanabe, M. Ohnuki, et al., “Induction of pluripo-

tent stem cells from adult human fibroblasts by defined factors,” Cell,

vol. 131, pp. 861–872, 11 2007.

[26] K. Nishino, K. Takasawa, K. Okamura, et al., “Identification of an epi-

genetic signature in human induced pluripotent stem cells using a linear

machine learning model,” Human Cell, vol. 34, pp. 99–110, 1 2021.

[27] M. van den Hurk, G. Kenis, C. Bardy, et al., “Transcriptional and epige-

netic mechanisms of cellular reprogramming to induced pluripotency,”

Epigenomics, vol. 8, pp. 1131–1149, 8 2016.

[28] J. Mao, Q. Saiding, S. Qian, et al., “Reprogramming stem cells in re-

generative medicine,” Smart Medicine, vol. 1, 12 2022.

[29] J. Gorecka, V. Kostiuk, A. Fereydooni, et al., “The potential and limita-

tions of induced pluripotent stem cells to achieve wound healing,” Stem

Cell Research and Therapy, vol. 10, p. 87, 12 2019.

[30] Y. Oh and J. Jang, “Directed differentiation of pluripotent stem cells by

transcription factors,” Molecules and cells, vol. 42, pp. 200–209, 3 2019.

[31] V. K. Singh, M. Kalsan, N. Kumar, et al., “Induced pluripotent stem

cells: applications in regenerative medicine, disease modeling, and drug

discovery,” Frontiers in cell and developmental biology, vol. 3, p. 2, 2015.